Literature DB >> 26360689

Early Risk Stratification with Dipyridamole Stress Echo in a Patient with Intermediate Lesion in the Right Coronary Artery, 24 Hours after Percutaneous Coronary Intervention.

S Carmargo1, R D Rampersad2.   

Abstract

Entities:  

Year:  2015        PMID： 26360689      PMCID： PMC4696622          DOI： 10.7727/wimj.2013.141

Source DB:  PubMed          Journal:  West Indian Med J        ISSN： 0043-3144            Impact factor:   0.171


× No keyword cloud information.
  13 in total

1.  Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study.

Authors:  R Sicari; E Picano; P Landi; A Pingitore; R Bigi; C Coletta; J Heyman; F Casazza; M Previtali; W Mathias; C Dodi; G Minardi; J Lowenstein; X Garyfallidis; L Cortigiani; M A Morales; M Raciti
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

2.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

3.  Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance.

Authors:  L Bolognese; L Rossi; G Sarasso; M D Prando; A S Bongo; P Dellavesa; P Rossi
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

4.  Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.

Authors:  D Poldermans; P M Fioretti; T Forster; I R Thomson; E Boersma; E M el-Said; N A du Bois; J R Roelandt; H van Urk
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

5.  Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease.

Authors:  K M Kent; D R Rosing; C J Ewels; L Lipson; R Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

6.  Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease.

Authors:  D Poldermans; P M Fioretti; E Boersma; J H Cornel; F Borst; E G Vermeulen; M Arnese; A el-Hendy; J R Roelandt
Journal:  Am J Med       Date:  1994-08       Impact factor: 4.965

7.  Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography.

Authors:  S Severi; E Picano; C Michelassi; F Lattanzi; P Landi; A Distante; A L'Abbate
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

8.  Prediction of major cardiac events after peripheral vascular surgery using dipyridamole echocardiography.

Authors:  M D Tischler; T H Lee; A T Hirsch; C P Lord; L Goldman; M A Creager; R T Lee
Journal:  Am J Cardiol       Date:  1991-09-01       Impact factor: 2.778

9.  Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease.

Authors:  P K Mazeika; A Nadazdin; C M Oakley
Journal:  Am J Cardiol       Date:  1993-01-01       Impact factor: 2.778

10.  Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death.

Authors:  P J Harris; K L Lee; F E Harrell; V S Behar; R A Rosati
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.